Prescription of drugs during pregnancy in France
Prescription of drugs during pregnancy in France
复制标题
DOI：
10.1016/s0140-6736(00)03209-8
复制
发表时间：
2000-11-18
期刊：
影响因子：
168.9
通讯作者：
Montastruc, J
中科院分区：
文献类型：
--
作者：
Lacroix, I;Damase-Michel, C;Montastruc, J
对居住在法国西南部上加隆的1000名妇女的怀孕期间药物处方记录进行的一项调查显示，99%的妇女在怀孕期间至少获得一种药物的处方，平均每位妇女服用13.6种药物。1.6%的妇女接受了美国食品和药物管理局X类药物的一个或多个处方（胎儿风险大于益处）。59%的妇女有D类药物的处方（胎儿风险，但益处可能是可以接受的），79%的妇女接触的药物在怀孕期间的安全性信息无法从动物或人体研究中获得。
A survey of the records of the French Health Insurance Service of drug prescriptions during pregnancy in 1000 women living in Haute-Garonne, southwest France, showed that 99% of the women received a prescription for at least one drug during pregnancy with a mean of 13.6 medications per woman. 1.6% of women received one or more prescriptions of drugs from the US Food and Drug Administration X category (fetal risk outweighs benefits). 59% of women had a prescription of drugs from the D category (fetal risk but benefits may be acceptable) and 79% of women were exposed to drugs for which information about safety in pregnancy was not available from animal or human studies.